Tay et al.
and CD3CN using CaH2. Silica gel (Merck Kieselgel 60, 230-400
mesh) was dried at 140 °C overnight before use. The tetraalky-
ldithiuram disulfides [R2NC(S)S]2 (R ) Me, Et), isopropylxanthic
disulfide [iPrOC(S)S]2, and RuCl3‚nH2O were purchased from
Merck and used as supplied. [Cp*RuCl2]n (1),22 [Cp*RuCl2(S2-
at -30 °C for 30 min, did not give any solid product. Then the
solution was evacuated to dryness and redissolved in 1 mL of
toluene. The addition of hexane (1 mL) gave microcrystalline 4
(50 mg, 0.096 mmol, 59%). Anal. Calcd for C16H29Cl2O2P1Ru1S2:
C, 36.9; H, 5.6; S, 12.3; P, 6.0. Found: C, 37.4; H, 5.7; S, 12.0; P,
24
1
CNMe2)] (2a),23 and bis(thiophosphoryl) disulfide [(iPrO)2P(S)S]2
5.8. H NMR (500 MHz, CD3CN): δ 1.31 (s, 15H, Me5C5), 1.34
3
3
were prepared according to published procedures.
(d, JHH ) 6.3 Hz, 12H, CH(CH3)2), 4.76 (d of septet, JHH ) 6.3
Hz, 3JPH ) 10.7 Hz, 1H, CH(CH3)2) and 5.00 (d of septet, 3JHH
)
Reactions of [Cp*RuCl2]2 (1). (a) With [Et2NC(S)S]2. Syn-
thesis of [Cp*RuCl2(S2CNEt2)] (2b). To an orange-red solution
of 1 (0.54 g, 0.88 mmol) in acetonitrile (10 mL) was added [Et2-
NC(S)S]2 (0.26 g, 0.88 mmol) with stirring. The solution turned
purple instantly. The resultant solution was filtered through a disc
(2 cm) of silica gel. Concentration of the filtrate in vacuo to ca. 3
mL, followed by the addition of ether (5 mL) and subsequent
cooling at -30 °C for 30 min, gave a microcrystalline solid of 2b
(0.67 g, 1.46 mmol, 85%). Anal. Calcd for C15H25Cl2NRuS2: C,
39.6; H, 5.5; N, 3.1; S, 14.1; Cl, 15.6. Found: C, 39.7; H, 5.7; N,
6.3 Hz, 3JPH ) 13.3 Hz, 1H, CH(CH3)2). 13C{1H} NMR (500 MHz,
3
CD3CN): δ 9.0 (Me5C5), 24.1 and 24.2 (each d, JPC ) 4.6 Hz,
CH3), 75.7 and 76.1 (each d, JPC ) 7.3 and 5.0 Hz, respectively,
2
CH), 108.8 (Me5C5). 31P NMR (500 MHz, CD3CN): δ 95.2 (dd,
3JPH ) 10.4 and 12.4 Hz). IR (KBr, cm-1): ν 2979m, 2930w,
2909w, 2868vw, 1475mbr, 1376s, 1173w, 1143w, 1097m, 983vs,
961vs, 890wsh, 771s, 640m (PdS). FAB+-MS: m/z 480 [M - iPr
+ 3H)]+, 449 [M - 2Cl]+, 366 [M - S2P(OiPr)]+, 351 [M -
S2P(OiPr) - Me]+, 300 [Cp*RuS2]+, 268 [Cp*RuS], 234 [Cp*Ru
- 2H]+, and significant unassigned higher mass fragments, 557,
588, and 663. The compound is very soluble in all organic solvents
and, unlike 2 and 3, is very air-sensitive even in the solid state.
Dichlorido Substitution. (a) Using Et2NC(S)S-. Synthesis of
[Cp*Ru(S2CNMe2)(S2CNEt2)]Cl (5a). To a purple solution of 2a
(46 mg, 0.11 mmol) in acetonitrile (4 mL) was added Na(S)SCNEt2
(24 mg, 0.11 mmol) with stirring. The solution turned red in 1 h.
The resultant solution was filtered through a disc (2 cm) of Celite.
Concentration of the filtrate in vacuo to ca. 1 mL, followed by the
addition of ether (2 mL) and subsequent cooling at -30 °C for 30
min, gave a microcrystalline solid of 5a (40 mg, 0.074 mmol, 69%).
Anal. Calcd for C18H31ClN2RuS4: C, 40.0; H, 5.8; N, 5.2; S, 23.7.
Found: C, 39.9; H, 6.1; N, 5.0; S, 23.9. 1H NMR (CDCl3): δ 1.60
1
3.3; S, 14.4; Cl, 16.4. H NMR (CDCl3): δ 1.30 (t, J ) 7.2 Hz,
6H, 2CH3), 1.41 (s, 15H, Me5C5), 3.73 (q, J ) 7.2 Hz, 4H, 2CH2).
13C{1H} NMR (CDCl3): δ 8.2 (Me5C5), 12.5 (CH3), 42.7 (CH2),
106.3 (Me5C5), 204.3 (CS). IR (KBr, cm-1): ν 1517vs (C-N),
1089s, 1010m (NC2), 859m, 783m (C-S). FAB+-MS: m/z 415
[M - Et - Me + 2H]+ 385 [M - 2Cl]+, 370 [M - 2Cl - Me]+,
352 [M - 2Cl - 2Me - 3H]+, 313 [M - 2Cl - NEt2]+, 300
[Cp*RuS2]+, 268 [Cp*RuS]+, 236 [M - 2Cl - SCNEt2
)
Cp*Ru]+, and higher mass fragments, the significant ones of which
are 492 [M + Cl]+ and 522 [M + Cl + 2Me]+. The complex is
sparingly soluble in toluene and ether, moderately soluble in
tetrahydrofuran, and highly soluble in acetonitrile and chloro
solvents. Solid samples are air-stable, and solutions in CD3Cl were
found unchanged when checked after 3 days at room temperature.
3
(s, 15H, Me5C5), 1.31 (t, JHH ) 7.2 Hz, 6H, CH2CH3), 3.37 (s,
6H, CH3), 3.76 and 3.73 (each dq, 2JHH ) 14.4 Hz, 2H, CH2CH3).
13C{1H} NMR (CDCl3): δ 8.8 (Me5C5), 12.3 (CH3), 38.0 (CH2CH3),
43.8 (CH2CH3), 105.7 (Me5C5), 204.3 and 205.2 (each CS). IR
(KBr, cm-1): ν 1560vs, 1527vs (C-N), 1156m, 1086m, 1018m
(NC2), 851w, 784w (C-S). FAB+-MS: m/z 505 [M - Cl]+, 477
[M - Cl - Et], 385 [M - Cl - (S2CNMe2)]+, 357 [M - Cl -
(S2CNEt2)]+, 300 [Cp*RuS2], 281 [M - Cp* - Cl - CNEt2 -
5H]+, 268 [Cp*RuS], 236 [Cp*Ru], and a higher mass fragment
533 [M - Cl + Et - H]+.
(b) With [iPrOC(S)S]2. Synthesis of [Cp*RuCl2(S2COiPr)] (3).
Similarly, from the reaction of 1 (0.40 g, 0.66 mmol) with [iPrOC-
(S)S]2 (0.18 g, 0.66 mmol) was obtained microcrystalline 3 (0.53
g, 1.20 mmol, 89%). Anal. Calcd for C14H22Cl2ORuS2: C, 38.0;
H, 5.0; S, 14.5; Cl, 16.0. Found: C, 37.6; H, 4.7; S, 14.9; Cl, 16.4.
3
1H NMR (CDCl3): δ 1.45 (s, 15H, Me5C5), 1.50 (d, JHH ) 6.0
Hz, 6H, CH(CH3)2), 5.64 (septet, 1H, CH(CH3)2). 1H NMR (CD3-
3
CN): δ 1.37 (s, 15H, Me5C5), 1.49 (d, JHH ) 6.0 Hz, 6H, CH-
(CH3)2), 5.69 (septet, 1H, CH(CH3)2). 13C{1H} NMR (CDCl3): δ
8.4 (Me5C5), 21.9 (CH3), 107.2 (Me5C5), 222.8 (CS), CH not
observed (presumably obscured by the solvent peaks at δ 77.0).
IR (KBr, cm-1): ν 1460s, 1372vs, 1280vs (C-O), 1094s 1041m,
900m (C-S), 811m (C-S). FAB+-MS: m/z 442 [M - 2H]+, 407
[M - 2H - Cl]+, 372 [M - 2H - 2Cl]+, 329 [M - 2H - 2Cl -
(iPr)]+, 300 [M - 2Cl - (COiPr) ) Cp*RuS2]+, 268 [Cp*RuS]+,
234 [Cp*Ru - 2H]+, and higher mass fragments, the significant
ones of which are 479 [M + Cl]+, 511 [M + Cl + S]+, 539 [M +
Cl + SCO]+, 610 [M + 3Cl + SCO]+, and 851. The complex is
similar to 2 in solubility and stability.
Synthesis of [Cp*Ru(S2CNEt2)2]Cl (5b). A similar reaction of
2b (50 mg, 0.11 mmol) with Na(S)SCNEt2 (25 mg, 0.11 mmol),
followed by a similar workup, gave microcrystalline 5b (60 mg,
0.11 mmol, 96%). Anal. Calcd for C20H35ClN2RuS4‚CH3Cl: C,
40.8; H, 6.2; N, 4.5; S, 20.7. Found: C, 41.0; H, 6.2; N, 4.8; S,
20.2. 1H NMR (500 MHz, CD3CN): δ 1.52 (s, 15H, Me5C5), 1.24
(t, 3JHH ) 6.9 Hz, 12H, CH3), 3.73 and 3.69 (each dq, 2JHH ) 14.5
Hz, 4H, CH2CH3). 13C{1H} NMR (CDCl3): δ 8.9 (Me5C5), 12.4
(CH3), 43.8 (CH2), 105.8 (Me5C5), 204.4 (CS). IR (KBr, cm-1): ν
1532vs, 1443s (C-N), 1075m, 1014w (NC2), 857w, 786w (C-S).
FAB+-MS: m/z 533 [M - Cl]+, 385 [M - Cl - (S2CNEt2)]+.
Synthesis of Cp*Ru(S2CNEt2)(S2CO) (6b). A similar reaction
of 3 (30 mg, 0.068 mmol) with Na(S)SCNEt2 (15 mg, 0.068 mmol),
followed by a similar workup, gave microcrystalline 6b (30 mg,
0.063 mmol, 93%). Anal. Calcd for C16H25NORuS4: C, 40.3; H,
(c) With [(iPrO)2P(S)S]2. Synthesis of Cp*RuCl2(S2P(OiPr)2)
(4). To an orange-red solution of 1 (50 mg, 0.081 mmol) in
acetonitrile (4 mL) was added [(iPrO)2P(S)S]2 (35 mg, 0.081 mmol)
with stirring. The solution gradually turned maroon in color. After
1 h, the resultant solution was filtered through a disc (2 cm) of
silica gel. Concentration of the filtrate in vacuo to ca. 1 mL,
followed by the addition of ether (2 mL) and subsequent cooling
1
5.3; N, 2.9; S, 26.9. Found: C, 39.9; H, 5.4; N, 2.8; S, 27.5. H
3
NMR (CD3CN): δ 1.49 (s, 15H, Me5C5), 1.23 (t, JHH ) 7.2 Hz,
6H, CH2CH3), 3.78-3.59 (overlapping dq, resembling ABX3
spectrum of 5a, total 4H, CH2CH3). 13C{1H} NMR (CDCl3): δ
8.5 (Me5C5), 12.4 (CH2CH3), 43.0 (CH2CH3), 102.9 (Me5C5), 202.7
and 206.8 (CS, S2CO). IR (KBr, cm-1): ν 1704m (CdO), 1593vs,
1513vs (C-N), 1076s, 1018s (NC2), 850s (C-S). FAB+-MS: m/z
478 [MH]+, 417 [M - 2Et - 2H]+, 385 [M - (S2CO)]+, 300
(22) Koelle, U.; Kossakowski, J. Inorg. Synth. 1992, 29, 225.
(23) Kuan, S. L.; Tay, E. P. L.; Leong, W. K.; Goh, L. Y.; Lin, C. Y.;
Gill, P. M. W.; Webster, R. D. Organometallics 2006, 25, 6134.
(24) (a) Kuchen, W.; Mayatepek, H. Chem. Ber. 1968, 101, 3454. (b)
Higgins, Wm. A.; Vogel, P. W.; Craig, W. G. J. Am. Chem. Soc. 1955,
77, 1864.
1442 Inorganic Chemistry, Vol. 46, No. 4, 2007